Super Patch vs Kailo: An Honest Comparison (2026)
Two drug-free patches, two published studies — and one detail nobody else mentions.
Disclosure: I'm an affiliate for Super Patch. I earn a commission if you buy through my links, and I earn nothing from Kailo. Weigh everything below with that in mind — which is exactly why this page shows you the evidence instead of asking you to trust me.
The short answer
Super Patch and Kailo are both drug-free adhesive patches that claim to reduce pain without delivering any substance through the skin, and both cite a published clinical study. Those studies were run by the same research organisation — Clarity Science LLC — with an overlapping author team, and each was paid for by the company selling the product. The meaningful difference is study design: Super Patch's RESTORE study was randomized, double-blind and placebo-controlled (118 adults, Pain and Therapy, 2025), while Kailo's PREVENT study was observational, with no randomization and no placebo control (148 patients, Anesthesia & Pain Research, 2022). A randomized placebo-controlled trial can separate a real effect from a placebo effect; an observational study cannot. Neither product is FDA-approved to treat any condition, neither study has been independently replicated, and results vary between individuals.
The thing nobody else mentions: it's the same lab
Every comparison of these two products I could find treats them as rivals with separate scientific stories. They aren't, quite.
Kailo's PREVENT study lists Jeffrey Gudin, Derek Dietze and Peter Hurwitz as authors. It states plainly that it was “administered by Clarity Science LLC and was funded by Pain Relief Technologies, the distributors of the Kailo Pain Patch.” It appeared in Anesthesia & Pain Research.
Super Patch's HARMONI pain study lists Jeffrey Gudin, Derek Dietze, Galen Dhaliwal and Peter Hurwitz. Clarity Science LLC, Narragansett, Rhode Island. Also Anesthesia & Pain Research.
Same lead author. Same research organisation. Same journal. Two competing products.
This is not a scandal and I'm not presenting it as one. Contract research organisations serve many clients, and there is nothing improper about a specialist firm running studies for several companies in one category. But it means one thing worth holding onto: “it has a published study” does not separate these two products. Both have one, from the same place. To tell them apart on evidence you have to look at what the studies actually did.
Head to head
| Super Patch | Kailo | |
|---|---|---|
| Claimed mechanism | A moulded surface texture that mechanically stimulates nerve endings in the skin (“vibrotactile trigger technology”) | A flexible array of nanocapacitors said to interact with the body's electrical signalling |
| Delivers anything through skin? | No | No |
| Powered? | No | No |
| Best published study | RESTORE — Pain and Therapy, 2025 | PREVENT — Anesthesia & Pain Research, 2022 |
| Study design | Randomized, double-blind, placebo-controlled | Observational, with a crossover group; not randomized, no placebo |
| Participants | 118 | 148 |
| Who paid for it | The manufacturer | Pain Relief Technologies, the Kailo distributor |
| Who ran it | Clarity Science LLC | Clarity Science LLC |
| Independently replicated? | No | No |
| FDA-approved to treat a condition? | No | No |
| Format | Single-use patches sold in packs | Reusable device, marketed as lasting about a year |
The evidence, honestly
What RESTORE showed
RESTORE was a prospective, randomized, double-blind, placebo-controlled trial of 118 adults using the FREEDOM Super Patch over 14 days, published in Pain and Therapy in 2025. It reported a meaningful reduction in pain severity and interference against placebo.
The caveats, which I state every time: it was funded by the manufacturer, authors were compensated in connection with the research, it is a single study, and nobody independent has replicated it. It measured pain over 14 days — not sleep, not energy, not focus, not anxiety. Any claim beyond pain is not supported by this trial.
What PREVENT showed
PREVENT enrolled 148 patients across three US clinical sites and reported reductions in pain severity and interference. It is a real, IRB-approved study and I'm not dismissing it.
But it was observational. Patients were not randomized and there was no placebo patch — everyone knew what they were getting. In a pain study that distinction is close to decisive, because pain is subjective and expectation is powerful, which is the exact thing a placebo control exists to rule out. An observational study can tell you people felt better. It cannot tell you the patch is why.
Where that leaves the comparison
On study design, Super Patch is ahead, and it isn't close — a randomized, double-blind, placebo-controlled trial is a materially stronger piece of evidence than an unrandomized observational one. That is the honest evidence edge.
On independence, neither is ahead. Both studies were paid for by the seller and run by the same organisation. Both need replication by someone with nothing at stake. Until that happens, the right posture toward both products is interested, not convinced.
The mechanism question
Kailo's claim is the harder one to accept. A passive, unpowered array of capacitors sitting on the skin has no established route to alter nerve signalling — capacitors store charge, they don't generate it. McGill University's Office for Science and Society published a critical examination of exactly this claim, and people with electronics backgrounds have raised the same objection repeatedly. That doesn't prove the patch does nothing, but the proposed explanation contains a step nobody has demonstrated.
Super Patch's claim is more modest: a physical texture pressing on skin does stimulate mechanoreceptors, and vibrotactile stimulation has an independent research literature behind it. “More plausible” is not “proven,” and those independent studies were run on other devices — they support the idea that the mechanism could matter, not that this product works.
Practical differences that may matter more
- Cost shape. Kailo is a reusable device. Super Patch is single-use, bought in packs, so it's an ongoing cost.
- Placement. Kailo is positioned over the painful area and often needs repositioning to find the right spot. Super Patch is chosen by product type rather than by hunting for a location.
- Returns. Check the current refund window, who pays return shipping, and whether it still applies once opened — for both. This changes more often than the science does.
- How it's sold. Super Patch is sold through a multi-level marketing structure, so much of what you'll read about it was written by someone who earns when you buy — including this page.
Who I'd honestly point where
If you want the strongest available evidence, Super Patch has it — one randomized, placebo-controlled trial, with the funding caveats attached.
If you'd rather buy once than repeatedly, Kailo's reusable format may suit you better, and you should go in knowing its study can't separate the product from placebo.
If you have persistent or worsening pain, neither of these is the answer and I'd rather say so. Get a diagnosis. The interventions with the best evidence for chronic pain remain the unglamorous ones: graded movement and strengthening, sleep, pacing, and treating the underlying cause. A patch of any brand is a small optional layer on top of that, never a substitute for it.
Frequently asked questions
Is Super Patch better than Kailo?
On evidence quality, yes — Super Patch's RESTORE study was randomized, double-blind and placebo-controlled, while Kailo's PREVENT study was observational with no placebo control. On independence, neither is better: both studies were funded by the seller and administered by the same organisation, Clarity Science LLC, and neither has been independently replicated.
Do Super Patch and Kailo use the same technology?
No. Super Patch uses a moulded surface texture intended to stimulate nerve endings mechanically. Kailo uses a nanocapacitor array said to interact with the body's electrical signalling. Neither delivers any drug through the skin, and neither is powered.
Are Super Patch or Kailo FDA-approved?
No. Neither is FDA-approved to treat any condition. Both are sold as general wellness products, which means no agency has reviewed them for treating a medical condition.
Is there independent research on either patch?
Not on the products themselves. Every study on either patch to date was funded by the company selling it. Independent research on vibrotactile stimulation exists, but it was conducted on other devices, so it supports the plausibility of the mechanism rather than the effectiveness of any particular patch.
Why do both patches' studies come from the same organisation?
Clarity Science LLC is a contract research organisation that runs sponsor-funded studies for multiple companies in the drug-free pain-relief category. There is nothing improper about that arrangement, but it means “backed by a published study” does not distinguish these two products from each other.
Not medical advice. Neither product is FDA-approved to treat, cure or prevent any condition. Individual results vary. Speak to a qualified clinician about persistent pain. Last reviewed August 2026.
Related reading: the full research library · is Super Patch a scam? · does Super Patch work?